4.6 Article

Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping

Journal

ALZHEIMERS RESEARCH & THERAPY
Volume 14, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13195-022-00962-4

Keywords

Alzheimer's disease (AD); Genetics; Haplotypes; Apolipoprotein E (APOE); rs439401; Novel approaches

Funding

  1. Iqbal Farrukh & Asad Jamal Fund
  2. NIH [AG060747, AG047366, AG066206, AG066515]
  3. European Union's Horizon 2020 research and innovation program [890650]
  4. Alzheimer's Association [AARF-20-683984]
  5. Marie Curie Actions (MSCA) [890650] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

Careful consideration of APOE genotype and appropriate sample filtering are crucial for robustly interrogating the role of the APOE locus on AD risk. This study presents a novel APOE filtering approach and provides important guidelines for research into the APOE locus, as well as for elucidating genetic interaction effects with APOE*2/3/4.
Background Genetic variants within the APOE locus may modulate Alzheimer's disease (AD) risk independently or in conjunction with APOE*2/3/4 genotypes. Identifying such variants and mechanisms would importantly advance our understanding of APOE pathophysiology and provide critical guidance for AD therapies aimed at APOE. The APOE locus however remains relatively poorly understood in AD, owing to multiple challenges that include its complex linkage structure and uncertainty in APOE*2/3/4 genotype quality. Here, we present a novel APOE*2/3/4 filtering approach and showcase its relevance on AD risk association analyses for the rs439401 variant, which is located 1801 base pairs downstream of APOE and has been associated with a potential regulatory effect on APOE. Methods We used thirty-two AD-related cohorts, with genetic data from various high-density single-nucleotide polymorphism microarrays, whole-genome sequencing, and whole-exome sequencing. Study participants were filtered to be ages 60 and older, non-Hispanic, of European ancestry, and diagnosed as cognitively normal or AD (n = 65,701). Primary analyses investigated AD risk in APOE*4/4 carriers. Additional supporting analyses were performed in APOE*3/4 and 3/3 strata. Outcomes were compared under two different APOE*2/3/4 filtering approaches. Results Using more conventional APOE*2/3/4 filtering criteria (approach 1), we showed that, when in-phase with APOE*4, rs439401 was variably associated with protective effects on AD case-control status. However, when applying a novel filter that increases the certainty of the APOE*2/3/4 genotypes by applying more stringent criteria for concordance between the provided APOE genotype and imputed APOE genotype (approach 2), we observed that all significant effects were lost. Conclusions We showed that careful consideration of APOE genotype and appropriate sample filtering were crucial to robustly interrogate the role of the APOE locus on AD risk. Our study presents a novel APOE filtering approach and provides important guidelines for research into the APOE locus, as well as for elucidating genetic interaction effects with APOE*2/3/4.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Polygenic Effect on Tau Pathology Progression in Alzheimer's Disease

Anna Rubinski, Simon Frerich, Rainer Malik, Nicolai Franzmeier, Alfredo Ramirez, Martin Dichgans, Michael Ewers

Summary: This study aims to investigate the effect of polygenic variation on the rate of fibrillar-tau accumulation in Alzheimer's disease (AD). By combining 85 genetic risk variants of AD into a polygenic score (PGS), the researchers found that higher PGS was associated with faster tau accumulation and cognitive decline. Risk enrichment analysis using high PGS resulted in a 34% reduction in required sample size.

ANNALS OF NEUROLOGY (2023)

Article Multidisciplinary Sciences

Heritable defects in telomere and mitotic function selectively predispose to sarcomas

Mandy L. Ballinger, Swetansu Pattnaik, Piyushkumar A. Mundra, Milita Zaheed, Emma Rath, Peter Priestley, Jonathan Baber, Isabelle Ray-Coquard, Nicholas Isambert, Sylvain Causeret, Winette T. A. van der Graaf, Ajay Puri, Florence Duffaud, Axel Le Cesne, Beatrice Seddon, Coonoor Chandrasekar, Joshua D. Schiffman, Andrew S. Brohl, Paul A. James, Jean-Emmanuel Kurtz, Nicolas Penel, Ola Myklebost, Leonardo A. Meza-Zepeda, Hilda Pickett, Maya Kansara, Nicola Waddell, Olga Kondrashova, John Pearson, Andrew P. Barbour, Shuai Li, Tuong L. Nguyen, Diane Fatkin, Robert M. Graham, Eleni Giannoulatou, Melissa J. Green, Warren Kaplan, Shyamsundar Ravishankar, Joseph Copty, Joseph E. Powell, Edwin Cuppen, Kristel van Eijk, Jan Veldink, Jin-Hee Ahn, Jeong Eun Kim, R. Lor Randall, Kathy Tucker, Ian Judson, Rajiv Sarin, Thomas Ludwig, Emmanuelle Genin, Jean-Francois Deleuze, Michelle Haber, Glenn Marshall, Murray J. Cairns, Jean-Yves Blay, David M. Thomas

Summary: Cancer genetics has focused on epithelial malignancies, but this study explores specific pathways related to sarcomas, rare malignancies derived from embryonic mesoderm. Germline sequencing of sporadic cases and healthy controls reveals two sarcoma-specific pathways involved in mitotic and telomere functions. Centrosome gene variants are linked to specific tumors, while heritable defects in the shelterin complex increase susceptibility to sarcomas, melanomas, and thyroid cancers. These findings highlight the role of heritable defects in mitotic and telomere biology in sarcoma risk.

SCIENCE (2023)

Article Medical Laboratory Technology

Plasma Concentrations of Calcium and Risk of Alzheimer Disease-Observational and Genetic Studies

Jesper Qvist Thomassen, Borge G. Nordestgaard, Anne Tybjaerg-Hansen, Ruth Frikke-Schmidt

Summary: This study found that high plasma concentrations of calcium ions were associated with increased risk of Alzheimer's disease (AD), but no genetic associations were found. This suggests that the observational findings may be due to reverse causation or residual confounding.

CLINICAL CHEMISTRY (2023)

Article Cardiac & Cardiovascular Systems

Vegetarian or vegan diets and blood lipids: a meta-analysis of randomized trials

Caroline A. Koch, Emilie W. Kjeldsen, Ruth Frikke-Schmidt

Summary: Due to the increasing environmental focus, plant-based diets are gaining popularity. A systematic review and meta-analysis were conducted to examine the effect of vegetarian and vegan diets on blood lipid levels. The results showed that plant-based diets can reduce total cholesterol, low-density lipoprotein cholesterol, and apolipoprotein B levels.

EUROPEAN HEART JOURNAL (2023)

Review Cardiac & Cardiovascular Systems

Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia

Ida Juul Rasmussen, Ruth Frikke-Schmidt

Summary: Dementia is a major global challenge, but 40% of cases can be prevented. Prevention measures, such as reducing cardiovascular risk factors, are crucial for reducing the incidence of dementia. Genome-wide association studies can be useful for identifying novel pathogenic pathways and high-risk individuals.

EUROPEAN HEART JOURNAL (2023)

Review Biochemistry & Molecular Biology

Step by step: towards a better understanding of the genetic architecture of Alzheimer's disease

Jean-Charles Lambert, Alfredo Ramirez, Benjamin Grenier-Boley, Celine Bellenguez

Summary: Alzheimer's disease (AD) has a significant genetic component, and recent advancements in genome-wide association studies and collaborative research have improved our understanding of this component. The identification of various chromosomal regions and causal genes associated with AD risk has confirmed the involvement of major pathophysiological pathways and revealed new perspectives. Furthermore, large-scale sequencing projects have shown the impact of rare variants on AD risk. Translational research is now disseminating this knowledge, particularly through the development of genetic risk/polygenic risk scores to identify high-risk or low-risk subpopulations for AD. Further research and improvement in understanding the genetic component of AD are necessary, and genetics may ultimately redefine the boundaries and relationships between different neurodegenerative diseases.

MOLECULAR PSYCHIATRY (2023)

Article Psychiatry

Modifications of the endosomal compartment in fibroblasts from sporadic Alzheimer's disease patients are associated with cognitive impairment

Laura Xicota, Julien Lagarde, Fanny Eysert, Benjamin Grenier-Boley, Isabelle Rivals, Alexandra Botte, Sylvie Forlani, Sophie Landron, Clement Gautier, Cecilia Gabriel, Michel Bottlaender, Jean-Charles Lambert, Mounia Chami, Marie Sarazin, Marie-Claude Potier

Summary: Morphological alterations in the endosomal compartment were observed in post-mortem brains of Alzheimer's disease (AD) patients and Down syndrome (DS) patients who have a high risk of AD. In this study, fibroblasts from a well-characterized cohort of AD patients were analyzed to investigate the association between endosomal compartment and AD. The results revealed an increased volume of EEA1-positive puncta in fibroblasts from AD patients, which correlated with amyloid deposition in the brain and cognitive decline. Genetic risk factors for AD were also identified. In conclusion, the endosomal compartment in fibroblasts may serve as a peripheral cellular biomarker for amyloid deposition and cognitive decline in AD.

TRANSLATIONAL PSYCHIATRY (2023)

Article Medicine, General & Internal

Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

Jiao Luo, Jesper Qvist Thomassen, Celine Bellenguez, Benjamin Grenier-Boley, Itziar de Rojas, Atahualpa Castillo, Kayenat Parveen, Fahri Kuecuekali, Aude Nicolas, Oliver Peters, Anja Schneider, Martin Dichgans, Dan Rujescu, Norbert Scherbaum, Deckert Juergen, Steffi Riedel-Heller, Lucrezia Hausner, Laura Molina Porcel, Emrah Duezel, Timo Grimmer, Jens Wiltfang, Stefanie Heilmann-Heimbach, Susanne Moebus, Thomas Tegos, Nikolaos Scarmeas, Jordi Clarimon, Fermin Moreno, Jordi Perez-Tur, Maria J. Bullido, Pau Pastor, Raquel Sanchez-Valle, Victoria Alvarez, Merce Boada, Pablo Garcia-Gonzalez, Raquel Puerta, Pablo Mir, Luis M. Real, Gerard Pinol-Ripoll, Jose Maria Garcia-Alberca, Jose Luis Royo, Eloy Rodriguez-Rodriguez, Hilkka Soininen, Teemu Kuulasmaa, Alexandre de Mendonca, Shima Mehrabian, Jakub Hort, Martin Vyhnalek, Sven van der Lee, Caroline Graff, Goran Papenberg, Vilmantas Giedraitis, Anne Boland, Delphine Bacq-Daian, Jean-Francois Deleuze, Gael Nicolas, Carole Dufouil, Florence Pasquier, Olivier Hanon, Stephanie Debette, Edna Gruenblatt, Julius Popp, Luisa Benussi, Daniela Galimberti, Beatrice Arosio, Patrizia Mecocci, Vincenzo Solfrizzi, Lucilla Parnetti, Alessio Squassina, Lucio Tremolizzo, Barbara Borroni, Benedetta Nacmias, Sandro Sorbi, Paolo Caffarra, Davide Seripa, Innocenzo Rainero, Antonio Daniele, Carlo Masullo, Gianfranco Spalletta, Julie Williams, Philippe Amouyel, Frank Jessen, Patrick Kehoe, Tsolaki Magda, Giacomina Rossi, Pascual Sanchez-Juan, Kristel Sleegers, Martin Ingelsson, Ole A. Andreassen, Mikko Hiltunen, Cornelia Van Duijn, Rebecca Sims, Wiesje van der Flier, Agustin Ruiz, Alfredo Ramirez, Jean-Charles Lambert, Ruth Frikke-Schmidt

Summary: This genetic association study identifies novel genetic associations between high HDL cholesterol concentrations and high systolic blood pressure with increased risk of AD, potentially inspiring new drug targeting and improved prevention implementation.

JAMA NETWORK OPEN (2023)

Article Neurosciences

An Investigation into the Relationship of Circulating Gut Microbiome Molecules and Inflammatory Markers with the Risk of Incident Dementia in Later Life

Kolade Oluwagbemigun, Andrea Anesi, Urska Vrhovsek, Fulvio Mattivi, Pamela Martino Adami, Michael Pentzek, Martin Scherer, Steffi G. Riedel-Heller, Siegfried Weyerer, Horst Bickel, Birgitt Wiese, Matthias Schmid, John F. Cryan, Alfredo Ramirez, Michael Wagner, Ute Noethlings

Summary: The gut microbiome may play a role in dementia through producing bioactive molecules and promoting inflammation. The association between gut microbiome molecules, inflammatory markers, and dementia risk is complex and requires further investigation. This epidemiological study aimed to explore the link between selected gut microbiome molecules and inflammatory markers with dementia risk.

MOLECULAR NEUROBIOLOGY (2023)

Article Biochemistry & Molecular Biology

Epigenome-wide analysis identifies methylome profiles linked to obsessive-compulsive disorder, disease severity, and treatment response

Rafael Campos-Martin, Katharina Bey, Bjoern Elsner, Benedikt Reuter, Julia Klawohn, Alexandra Philipsen, Norbert Kathmann, Michael Wagner, Alfredo Ramirez

Summary: Obsessive-compulsive disorder (OCD) is a common mental disorder affecting around 2-3% of the population. This study investigated the epigenetic factors associated with OCD by analyzing DNA methylation patterns in 185 OCD patients and 199 controls. The researchers identified differentially methylated CpG positions and validated their findings using a subset of 12 CpGs. These CpGs were found to be related to genes associated with the sweet-compulsive brain hypothesis, suggesting a potential role of aberrant dopaminergic transmission in OCD pathogenesis.

MOLECULAR PSYCHIATRY (2023)

Article Multidisciplinary Sciences

Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

Yann Le Guen, Guo Luo, Aditya Ambati, Vincent Damotte, Iris Jansen, Eric Yu, Aude Nicolas, Itziar de Rojasj, Thiago Peixoto Leal, Akinori Miyashita, Celine Bellenguez, Michelle Mulan Lian, Kayenat Parveen, Takashi Morizono, Hyeonseul Park, Benjamin Grenier-Boley, Tatsuhiko Naito, Fahri Kucukali, Seth D. Talyansky, Selina Maria Yogeshwar, Vicente Sempere, Wataru Satake, Victoria Alvarez, Beatrice Arosio, Michael E. Belloy, Luisa Benussi, Anne Boland, Barbara Borroni, Maria J. Bullido, Paolo Caffarra, Jordi Clarimon, Antonio Daniele, Daniel Darling, Stephanie Debette, Jean-Francois Deleuze, Martin Dichgans, Carole Dufouil, Emmanuel During, Emrah Duzel, Daniela Galimberti, Guillermo Garcia-Ribas, Jose Maria Garcia-Alberca, Pablo Garcia-Gonzalez, Vilmantas Giedraitis, Oliver Goldhardt, Caroline Graff, Edna Grunblatt, Olivier Hanon, Lucrezia Hausner, Stefanie Heilmann-Heimbach, Henne Holstege, Jakub Hort, Yoo Jin Jung, Deckert Jurgen, Silke Kern, Teemu Kuulasmaa, Kun Ho Lee, Ling Lin, Carlo Masullo, Patrizia Mecocci, Shima Mehrabian, Alexandre de Mendonca, Merce Boada, Pablo Mir, Susanne Moebus, Fermin Moreno, Benedetta Nacmias, Gael Nicolas, Shumpei Niida, Borge G. Nordestgaard, Goran Papenberg, Janne Papma, Lucilla Parnetti, Florence Pasquier, Pau Pastor, Oliver Peters, Yolande A. L. Pijnenburg, Gerard Pinol-Ripoll, Julius Popp, Laura Molina Porcel, Raquel Puertaj Jordi Perez-Tur, Innocenzo Rainero, Inez Ramakers, Luis M. Real, Steffi Riedel-Heller, Eloy Rodriguez-Rodriguez, Owen A. Ross, Jose Luis Royo, Dan Rujescu, Nikolaos Scarmeas, Philip Scheltens, Norbert Scherbaum, Anja Schneider, Davide Seripa, Ingmar Skoog, Vincenzo Solfrizzi, Gianfranco Spalletta, Alessio Squassina, John van Swieten, Raquel Sanchez-Valle, Eng-King Tan, Thomas Tegos, Charlotte Teunissen, Jesper Qvist Thomassen, Lucio Tremolizzo, Martin Vyhnalek, Frans Verhey, Margda Waern, Jens Wiltfang, Jing Zhangc, Henrik Zetterberg, Kaj Blennow, Zihuai He, Julie Williams, Philippe Amouyel, Frank Jessen, Patrick G. Kehoe, Ole A. Andreassen, Cornelia Van Duin, Magda Tsolaki, Pascual Sanchez-Juan, Ruth Frikke-Schmidt, Kristel Sleegers, Tatsushi Todau, Anna Zettergren, Martin Ingelsson, Yukinori Okada, Giacomina Rossi, Mikko Hiltunen, Jungsoo Gim, Kouichi Ozaki, Rebecca Sims, Jia Nee Foo, Wiesje van der Fliere, Takeshi Ikeuchi, Alfredo Ramirez, Ignacio Mata, Agustin Ruiz, Ziv Gan-Or, Jean-Charles Lambert, Michael D. Greicius, Emmanuel Mignot

Summary: We analyzed the HLA associations in individuals with Parkinson's disease and Alzheimer's disease across different ancestry groups and found that these two diseases share a common protective association at the HLA locus. Fine-mapping showed that specific subtypes of HLA-DRB1*04 were responsible for this association, with HLA-DRB1*04:04 and HLA-DRB1*04:07 showing the strongest association. This protective effect was also associated with decreased neurofibrillary tangles in the brain and reduced levels of tau protein in cerebrospinal fluid.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Biology

Improving genetic risk prediction across diverse population by disentangling ancestry representations

Prashnna K. Gyawali, Yann Le Guen, Xiaoxia Liu, Michael E. Belloy, Hua Tang, James Zou, Zihuai He

Summary: Risk prediction models using genetic data are important in genomics. However, most models are developed using data from participants with similar ancestry, leading to poor prediction for minority populations. To address this, we propose a deep-learning framework that leverages diverse population data and separates ancestry from phenotype-relevant information, improving risk prediction for minority populations.

COMMUNICATIONS BIOLOGY (2023)

Article Nutrition & Dietetics

Low Serum Vitamin D Status Is Associated with Incident Alzheimer's Dementia in the Oldest Old

Debora Melo van Lent, Sarah Egert, Steffen Wolfsgruber, Luca Kleineidam, Leonie Weinhold, Holger Wagner-Thelen, Birgit Stoffel-Wagner, Horst Bickel, Birgitt Wiese, Siegfried Weyerer, Michael Pentzek, Frank Jessen, Matthias Schmid, Wolfgang Maier, Martin Scherer, Steffi G. G. Riedel-Heller, Alfredo Ramirez, Michael Wagner

Summary: Deficiency of vitamin D increases the risk of developing Alzheimer's dementia. It is recommended to monitor vitamin D levels in the elderly and provide supplementation in cases of deficiency.

NUTRIENTS (2023)

Article Clinical Neurology

Dementia with Lewy bodies: old and new knowledge-Part 2: treatment

Richard Dodel, Daniela Berg, Thomas Duning, Elke Kalbe, Philipp T. Meyer, Alfredo Ramirez, Alexander Storch, Dag Aarsland, Frank Jessen

Summary: The treatment of patients with Parkinson's disease-related dementia involves a variety of symptoms and complexities, and requires close cooperation with specialists to achieve effective treatment.

NERVENARZT (2023)

Letter Clinical Neurology

Association of MGMT and BIN1 genes with Alzheimer's disease risk across sex and APOE ε4 status

Julie Le Borgne, Philippe Amouyel, Ole Andreassen, Ruth Frikke-Schmidt, Mikko Hiltunen, Martin Ingelsson, Alfredo Ramirez, Giacomina Rossi, Agustin Ruiz, Pascual Sanchez-Juan, Rebecca Sims, Kristel Sleegers, Magda Tsolaki, Sven J. van der Lee, Julie Williams, Jean-Charles Lambert, Celine Bellenguez

ALZHEIMERS & DEMENTIA (2023)

No Data Available